Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125352901 | 12535290 | 1 | I | 201512 | 20160628 | 20160707 | 20160707 | EXP | DE-PFIZER INC-2016321487 | PFIZER | 59.00 | YR | F | Y | 76.00000 | KG | 20160707 | MD | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125352901 | 12535290 | 1 | PS | SUNITINIB MALATE. | SUNITINIB MALATE | 1 | Oral | 50 MG, UNK | 21938 | 50 | MG | CAPSULE, HARD | |||||||
125352901 | 12535290 | 2 | C | LISINOPRIL AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Oral | 1 DF (20MG/12.5MG), UNK | 0 | 1 | DF |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125352901 | 12535290 | 1 | Neuroendocrine tumour |
125352901 | 12535290 | 2 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125352901 | 12535290 | DS |
125352901 | 12535290 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125352901 | 12535290 | Encephalopathy | |
125352901 | 12535290 | Hypothyroidism | |
125352901 | 12535290 | Myxoedema | |
125352901 | 12535290 | Thyroiditis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125352901 | 12535290 | 1 | 201507 | 0 |